The drugmaker plans to acquire 33 percent stake in Avenue Therapeutics for $35 million at $6 per share, according to its stock exchange notification.
Shares of the pharmaceutical company fluctuated between gains and losses to trade at Rs 528.40.
Cipla Share Price
Cipla Share Price Gains On U.S. FDA Nod For Testosterone Injection
Gold Silver Reports (GSR) – Cipla Share Price Gains On U.S. FDA Nod For Testosterone Injection – Shares of the Mumbai-based drugmaker rose as much as 1 percent to Rs 609 after U.S. FDA gave its final approval to Abbreviated New Drug Application (ANDA) fot Testosterone Cypionate injection.